Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.

Jeffrey R Gardner, MBA, Sean Devlin, PhD, Kristina Knapp, Francesco Bauli, MS, Nicole Lamanna, MD, Mark G. Frattini, MD, PhD, Renier J Brentjens, MD, PhD, Peter G. Maslak, M.D., Joseph G. Jurcic, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD

Blood (2012) 120 (21): 2482.

https://doi.org/10.1182/blood.V120.21.2482.2482

Published: 2012

Journal Articles

Micafungin Versus Posaconazole Anti-Fungal Prophylaxis in Adult Patients with Acute Leukemia Undergoing Induction Chemotherapy

Elizabeth Halton, RN, MS, ANP, Dick Chung, BS, Kun Xiao, MS, MPH, Hilda Quintanilla, RN, MS, ANP, Christina Baldwin, RN, MS, ANP, Pamela Baird, RN, MS, ANP, Ellin Berman, MD, Renier J Brentjens, MD, PhD, Mark Heaney, MD, PhD, Joseph G. Jurcic, MD, Nicole Lamanna, MD, Todd L. Rosenblat, MD, Rana Kaplan, MD, Genovefa Papanicolaou, MD, Mark G. Frattini, MD, PhD

Blood (2012) 120 (21): 3556.

https://doi.org/10.1182/blood.V120.21.3556.3556

Published: 2012

Journal Articles

High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL)

Nicole Lamanna, MD, Mark Weiss, MD, Ellin Berman, MD, Mark G. Frattini, MD, PhD, Mark Heaney, MD, PhD, Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Heather Landau, MD, Hanna Weissbrot, BA, Peter G. Maslak, M.D.

Blood (2012) 120 (21): 4293.

https://doi.org/10.1182/blood.V120.21.4293.4293

Published: 2012

Journal Articles

Influence of National Comprehensive Cancer Network (NCCN) Guidelines on Clinical Practice in Patients with Chronic Myelogenous Leukemia (CML) Treated At a Single Academic Medical Center

Ellin Berman, MD, Cyrus V. Hedvat, MD, PhD, Joseph G. Jurcic, MD, Mark Heaney, MD, PhD, Peter G. Maslak, M.D., Renier Brentjens, MD, PhD, Nicole Lamanna, MD, Todd L. Rosenblat, MD, Mark G. Frattini, MD, PhD, Ann A Jakubowski, MD, PhD, Suresh Jhanwar, PhD

Blood (2011) 118 (21): 4433.

https://doi.org/10.1182/blood.V118.21.4433.4433

Published: 2011

Journal Articles

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Jeffrey R Gardner, MBA, Kristina Knapp, Mark G. Frattini, MD, PhD, Nicole Lamanna, MD, Renier Brentjens, MD, PhD, Joseph G Jurcic, MD, Peter G. Maslak, M.D., Ellin Berman, MD, Mark Weiss, MD, David A. Scheinberg, MD, PhD, Mark Heaney, MD, PhD

Blood (2011) 118 (21): 1765.

https://doi.org/10.1182/blood.V118.21.1765.1765

Published: 2011

Journal Articles

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Blood (2011) 118 (18): 4817–4828.

https://doi.org/10.1182/blood-2011-04-348540

Published: 2011

Includes: Supplemental data

Journal Articles

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Jeffrey R Gardner, MBA, Omar Abdel-Wahab, Mark Frattini, MD, Joseph G Jurcic, MD, Kristina Knapp, Todd L. Rosenblat, MD, MS, Gerald A. Soff, MD, Ross Levine, MD, Mark Heaney, MD, PhD

Blood (2010) 116 (21): 1992.

https://doi.org/10.1182/blood.V116.21.1992.1992

Published: 2010

Journal Articles

Characteristic Proinflammatory Serum Cytokine Profiles In Patients with B-Cell Chronic Lymphocytic Leukemia

James J. Harding, MD, Raymond Yeh, PhD, Yan Nikhamin, MS, MBA, Mark Frattini, MD, Nicole Lamanna, MD, Joseph G Jurcic, MD, Mark Heaney, MD, PhD, Renier Brentjens, MD, PhD

Blood (2010) 116 (21): 3595.

https://doi.org/10.1182/blood.V116.21.3595.3595

Published: 2010

Journal Articles

A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies

Swaminathan Padmanabhan, MBBS, MD, Kevin R Kelly, MD, Mark Heaney, MD, PhD, Stephanie Hodges, Suzanne Chanel, RN, Mark Frattini, MD, Ronan Swords, MD, MRCPI, FRCPath, Robert Bradley, Florentina Teofilovici, MD, MS, Daniel J DeAngelo, MD, PhD

Blood (2010) 116 (21): 2898.

https://doi.org/10.1182/blood.V116.21.2898.2898

Published: 2010

Journal Articles

Clinical Implementation of a Novel High-Throughput Screen of Primary Leukemia Cells to Customize Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML).

Kristen M O'Dwyer, M.D., David Shum, M.S., Mark Heaney, MD, PhD, Renier J. Brentjens, MD, PhD, Peter Maslak, MD, Joseph G Jurcic, MD, Hakim Djaballah, Ph.D., Mark G. Frattini, MD, PhD

Blood (2009) 114 (22): 2657.

https://doi.org/10.1182/blood.V114.22.2657.2657

Published: 2009

Journal Articles

Multivalent DNA Aptamer-Based Therapeutic Agents for Lymphoma and Leukemia.

Prabodhika Mallikaratchy, PhD, Alessandro Ruggiero, MD, William Maguire, Kelly Piersanti, Jeffrey Gardner, Carlos Villa, Freddy Escorcia, Maria Lia Palomba, MD, Mark Heaney, MD, PhD, Michael R. McDevitt, PhD, David A. Scheinberg, MD, PhD

Blood (2009) 114 (22): 2711.

https://doi.org/10.1182/blood.V114.22.2711.2711

Published: 2009

Journal Articles

Discovery and Validation of a Novel Class of Small Molecule Inhibitors of the CDC7 Kinase: Modulation of Tumor Cell Growth in Vitro and In Vivo .

Mark G. Frattini, MD, PhD, David Shum, M.S., Kristen M O'Dwyer, M.D., Renier J. Brentjens, MD, PhD, Peter Maslak, MD, Mark Heaney, MD, PhD, Joseph G Jurcic, MD, Hakim Djaballah, Ph.D., Thomas J Kelly, M.D., Ph.D.

Blood (2009) 114 (22): 3771.

https://doi.org/10.1182/blood.V114.22.3771.3771

Published: 2009

NARROW

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.

Micafungin Versus Posaconazole Anti-Fungal Prophylaxis in Adult Patients with Acute Leukemia Undergoing Induction Chemotherapy

High Dose Cytarabine and Mitoxantrone in Combination with Dasatinib As Active Induction Therapy in Adult Patients with Philadelphia Chromosome Positive (ph+) Acute Lymphoblastic Leukemia (ALL)

Influence of National Comprehensive Cancer Network (NCCN) Guidelines on Clinical Practice in Patients with Chronic Myelogenous Leukemia (CML) Treated At a Single Academic Medical Center

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Characteristic Proinflammatory Serum Cytokine Profiles In Patients with B-Cell Chronic Lymphocytic Leukemia

A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies

Clinical Implementation of a Novel High-Throughput Screen of Primary Leukemia Cells to Customize Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML).

Multivalent DNA Aptamer-Based Therapeutic Agents for Lymphoma and Leukemia.

Discovery and Validation of a Novel Class of Small Molecule Inhibitors of the CDC7 Kinase: Modulation of Tumor Cell Growth in Vitro and In Vivo .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only